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ABSTRACT
Import of nucleus-encoded tRNAs into the mito-
chondria of the kinetoplastid protozoon Leishmania
involves recognition of speci®c import signals by
the membrane-bound import machinery. Multiple
signals on different tRNA domains may be present,
and further, importable RNAs interact positively
(Type I) or negatively (Type II) with one another at
the inner membrane in vitro. By co-transfection
assays, it is shown here that tRNATyr (Type I)
transiently stimulates the rate of entry of tRNAIle
(Type II) into Leishmania mitochondria in trans-
fected cells, and conversely, is inhibited by tRNAIle.
Truncation and mutagenesis experiments led to the
co-localization of the effector and import activities
of tRNATyr to the D domain, and those of tRNAIle to
the variable region±T domain (V-T region), indicat-
ing that both activities originate from a single RNA±
receptor interaction. A third tRNA, human tRNALys,
is imported into Leishmania mitochondria in vitro as
well as in vivo. This tRNA has Type I and Type II
motifs in the D domain and the V-T region, respect-
ively, and shows both Type I and Type II effector
activities. Such dual-type tRNAs may interact simul-
taneously with the Type I and Type II binding sites
of the inner membrane import machinery.
INTRODUCTION
The mitochondria of a large number of species are de®cient in
one or several tRNA genes (1), and sustain translation of the
organellar genes by speci®c import of the corresponding
nucleus-encoded species from the cytoplasm (reviewed in 2).
The number and identities of the tRNAs imported vary widely:
from one in yeast (3) and marsupials (4), to about a dozen in
plants (5), to at least 24 in kinetoplastid protozoa such as
Leishmania and Trypanosoma, which lack all tRNA genes
(6,7). Such diversity raises the questions of speci®city, of the
multiplicity of tRNA receptors and import mechanisms, and of
the evolutionary origin of the import apparatus.
The recent development of in vitro import systems in yeast
(8), Leishmania (9,10), trypanosomes (11,12) and potato (13)
has enabled the interaction of tRNAs with mitochondria to be
studied in detail. Two distinct import mechanisms are now
recognized (2). The single-tRNA system in yeast appears to
involve protein import channels and soluble carriers, including
the cognate aminoacyl tRNA synthetase (14). This co-import
model differs from the direct import mechanism apparently
operating in kinetoplastid protozoa. Here soluble proteins are
not required, and the tRNA import and protein import
machineries are distinct (12,15). Speci®c sequence motifs
and/or structures (import signals) on tRNAs are recognized
(16,17). Moreover, by a selection-ampli®cation protocol on
Leishmania mitochondria, several import aptamers were
isolated, suggesting the occurrence of multiple signals in
different domains of various tRNAs (18). For example,
tRNATyr(GUA) contains an import signal that includes the
conserved motif YGGYAGAGC in the D domain (16,18),
while tRNAIle(UAU) has an import signal in the variable
region±T domain (V-T region) that contains the conserved
motif UGGGU (18). Some tRNAs may have more than one
signal; for example, human tRNALys(UUU), which is
imported into trypanosome mitochondria (19), as well as its
counterpart in Leishmania, contain both the D domain and the
V-T region motifs (18) (see below). An additional level of
complexity is that transfer of tRNA through the outer and
inner mitochondrial membranes appear to be kinetically and
biochemically separable processes (20). In particular, the
effects of mutations within the import signal on these two
steps are non-identical, suggesting the presence of distinct
receptors at the two membranes (17). A 15 kDa tRNA binding
protein is apparently required for outer membrane transfer
(21); the inner membrane receptors are yet to be identi®ed.
Of particular interest is the observation that in vitro,
importable RNAs, including oligonucleotide aptamers and
intact tRNAs, allosterically interact with one another at the
inner membrane (18). Two types of RNAs have been
observed: Type I RNAs, e.g. tRNATyr, can be imported into
the matrix by themselves, while Type II RNAs, e.g. tRNAIle,
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require the presence of low levels of a Type I RNA. Moreover,
Type II RNAs inhibit the transfer of Type I RNAs (18).
Although the generality of this phenomenon with respect to all
importable tRNAs is presently undetermined, the fact that
known Type I and Type II aptamers are homologous to a large
number of tRNAs (18) implies allosteric regulation to be
widely applicable. This type of regulation may serve to create
a balanced mitochondrial pool of tRNAs from a cytoplasmic
pool containing tRNAs of widely different intrinsic import
ef®ciencies.
In the present study, we have looked for evidence of such
allosteric interactions in vivo, examined the relationship
between the substrate and effector activities of tRNATyr and
tRNAIle, and studied the interactions involving tRNALys. The
results suggest the possibility of both sequential and simul-
taneous interactions between the Type I and Type II domains
and their cognate binding sites on the inner membrane.
MATERIALS AND METHODS
Preparation of mitochondria
Mitochondria were prepared from lysates of Leishmania
tropica strain UR6 promastigotes by Percoll gradient
centrifugation as previously described (9). To selectively
remove the outer membrane, mitochondria were treated with
320 mM digitonin (20). The resultant mitoplasts were
subjected to freeze±thaw cycles to separate the soluble
(matrix) and particulate (inner membrane) fractions (20).
The purity of individual fractions was assessed by marker
enzyme assays (20).
Import substrates and effectors
32P-labeled tRNATyr(GUA), tRNAGln(CUG) and tRNAIle-
(UAU) transcripts were prepared from cloned or PCR-
ampli®ed templates, and D domain RNAs from oligonucle-
otide templates bearing the stated mutations, using T7 RNA
polymerase (16±18,20,21) (Fig. 1). Truncated tRNAIle[1±41]
and tRNAIle[42±66] were obtained by run-off transcription
of the appropriate subclones (18). The human cytoplasmic
tRNALys1(UUU) gene (M.Sprinzl, K.S.Vassilenko, J.Emmerich
and F.Bauer, http://www.uni-bayreuth.da/departments/
biochemie/tRNA) was ampli®ed from human genomic DNA
by PCR using CGGGAATTCTAATACGACTCACTATAG-
CCCGGATAGCTCAGTCGG (sense) and TGGCGCCCG-
AACAGGGACTTG (antisense) as primers; the PCR product
on transcription yields a 3¢-CCA terminated transcript (Fig. 1).
Import substrates were prepared using a high speci®c activity
of [a-32P]UTP (~100 c.p.m./fmol), while effector RNAs were
synthesized at 1/250 of this speci®c activity (18).
In vitro import assays
Import into intact mitochondria or mitoplasts was assayed by
RNase protection as previously described (17). Brie¯y,
mitochondria (100 mg of protein) were incubated with 32P-
labeled RNA (2.5 nM) in the presence of 4 mM ATP at 37°C
for 15 min, then treated with RNases A plus T1, washed, and
the RNase-resistant mitochondrial RNA recovered for gel
electrophoretic analysis. To assess intra-mitochondrial distri-
bution of imported RNA, RNase-treated mitochondria were
fractionated as above, and RNA isolated from each fraction.
Binding assays
Mitochondria or mitoplasts were incubated with 32P-labeled
RNA (1 nM) in the presence of 0.1 M NaCl on ice for 30 min,
washed, and bound RNA recovered (21).
Transient transfection assays
Leishmania tropica promastigotes were electroporated in the
presence of 32P-labeled RNA, the cells were incubated at 22°C
for the indicated times, then lysed, and the particulate fraction
containing mitochondria was treated with DNase and RNase
before recovery of internalized RNA, as detailed previously
(17). The cellular pool was isolated by RNase treatment of an
aliquot of the transfected cells before lysis and preparation
of total RNA. For time course experiments, import was
terminated at the indicated times by the addition of 10 mM
m-chlorocarbonylcyanide phenylhydrazone (CCCP).
RESULTS
Inter-tRNA interactions in transiently transfected cells
It was previously shown that, in vitro, tRNATyr (a Type I
RNA) stimulates transfer of tRNAIle (a Type II RNA) across
the inner membrane (18). To assess the physiological
signi®cance of this observation, a transient transfection
assay was employed. Promastigotes were transfected with
32P-labeled tRNATyr, incubated at 22°C, and the total and
mitochondrial RNAs were isolated. Using this approach, we
have previously demonstrated speci®c, sequence-dependent
mitochondrial uptake of oligoribonucleotides (17). As shown
in Figure 2A, tRNATyr was recovered from the RNase-treated
mitochondrial fraction. In independent experiments, an
average of 69 6 14% (n = 4) of the total intracellular
transfecting RNA was present in mitochondria at 10 min post-
transfection. Treatment of this fraction with Triton X-100
during or before RNase treatment resulted in degradation of
the RNA, showing it to be membrane enclosed, but the RNA
was partially resistant to treatment with digitonin, which
selectively permeabilizes the outer mitochondrial membrane,
indicating its presence in the matrix. In the presence of the
protonophore uncoupler CCCP, which disrupts the proton
gradient generated by actively respiring mitochondria, uptake
was inhibited (Fig. 2A), showing the requirement of a
membrane potential for import, as has been previously
observed in vitro (17,20), as well as in vivo for import of
oligonucleotides (17,18). Mitochondrial uptake was similarly
inhibited by oligomycin, a speci®c inhibitor of the mitochon-
drial F1F0 ATPase (Fig. 2A). Moreover, uptake was speci®c
with respect to tRNA, since tRNAGln(CUG), which is not
imported in vivo (22), was not taken up by the mitochondrial
fraction (Fig. 2B).
To examine inter-tRNA interactions, promastigotes were
co-transfected with high speci®c activity, 32P-labeled tRNATyr
(substrate) and low speci®c activity tRNAIle (effector) at a
10:1 molar ratio. In the absence of effector, tRNATyr was
rapidly internalized by 10±15 min post-transfection with little
or no lag (Fig. 2C). In the presence of tRNAIle, a pronounced
lag of ~8 min was observed, but the total amount imported was
unaffected (Fig. 2C). In the reverse experiment, uptake of
tRNAIle alone was noticeably slower than that of tRNATyr (lag
of ~8 min), but the rate was enhanced by co-transfection with
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Figure 1. Structures of tRNAs and their derivatives. (A) Left, Leishmania tRNATyr(GUA). The conserved D arm signal is shown in red. Right, D arm mini-
helices, with mutations in blue. (B) Left, Leishmania tRNAIle(UAU); the conserved V-T region signal is shown in green. Right, truncated versions of
tRNAIle[1±41] and tRNAIle[42±66]. (C) Human cytoplasmic tRNALys(UUU) with conserved D arm (red) and V-T (green) motifs. (D) tRNAGln(CUG).
Figure 2. Mitochondrial uptake of tRNAs in transfected cells. (A) Leishmania tropica promastigotes (4.3 3 108) were electroporated with 32P-labeled
tRNATyr (500 fmol) in the absence (lanes 1±4) or presence of 10 mM CCCP (lanes 5 and 6) or 50 mM oligomycin (lanes 7 and 8). Aliquots of the transfected
cells were lysed and mitochondrial fractions were treated with RNase and DNase in the absence (lanes 2, 6 and 8) or presence of 1% Triton X-100 (lane 3) or
320 mM digitonin (lane 4), before recovery and analysis of RNA in the particulate fraction. The corresponding total cellular pools (lanes 1, 5 and 7) were
obtained by treating an identical aliquot of intact transfected cells with RNase before RNA isolation. (B) Transfection of promastigotes with 32P-labeled
tRNAGln(CUG). Lane 1, total cellular pool; lane 2, mitochondrial fraction; lane 3, mitochondrial fraction treated with Triton X-100. (C) Kinetics of uptake of
tRNATyr. Promastigotes were transfected with 500 fmol of high speci®c activity tRNATyr alone (lanes 1±6) or with 50 fmol of low speci®c activity tRNAIle
(lanes 7±12). After incubation at 22°C for the indicated times, import was terminated by the addition of 10 mM CCCP, aliquots of transfected cells were lysed
and RNase-resistant RNA in the mitochondrial fraction was recovered. Lane 13, input tRNATyr, 3 fmol. (D) Promastigotes were transfected with 500 fmol of
high speci®c activity tRNAIle alone (lanes 1±6) or with 50 fmol of low speci®c activity tRNATyr (lanes 7±12) for the indicated times at 22°C, import
terminated, and the mitochondrial uptake analyzed. Lane 13, input tRNAIle, 2 fmol. Quantitative data in (C) and (D) are graphically represented below the
respective autoradiograms. Open circles, substrate alone; ®lled circles, substrate plus effector. (E) 32P-labeled high speci®c activity tRNATyr (S, 500 fmol) was
co-transfected into promastigotes with low speci®c activity tRNAIle (E) at an E:S ratio of 0 (lanes 1 and 4), 1:10 (lanes 2 and 5) or 1:5 (lanes 3 and 6). Cells
were incubated for 10 min at 22°C before analysis of total (lanes 1±3) or mitochondrial (lanes 4±6) RNA. Lane 7, input tRNATyr (1 fmol). (F) 32P-labeled
high speci®c activity tRNAIle (S, 500 fmol) was co-transfected into promastigotes with low speci®c activity tRNATyr (E) at an E:S ratio of 0 (lanes 1 and 4),
1:10 (lanes 2 and 5) or 1:5 (lanes 3 and 6), and mitochondrial uptake was determined as in (E). Lane 7, input tRNAIle (1 fmol). Quanti®cations were
performed by densitometry. The total cellular pool was taken as 100% in each case.
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tRNATyr effector, with little effect on the ®nal yield (Fig. 2D).
These effects were reproducible in three independent experi-
ments, although the absolute value of the lag varied between 6
and 10 min, possibly a result of variations in the growth state
of the unsychronized cell population used for transfection.
Thus, effector activity in vivo is transient, being apparent only
at early times post-transfection (within 10 min at 22°C). In a
second set of experiments, early-time co-transfections were
performed at different substrate:effector ratios. Dose-
dependent inhibition of uptake of tRNATyr by tRNAIle
(Fig. 2E), and stimulation of uptake of tRNAIle by tRNATyr
(Fig. 2F), were observed.
Speci®city of effector action
The intra-mitochondrial distribution of tRNAIle imported
in vitro was assessed by fractionating post-import
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mitochondria into outer membrane plus intermembrane space,
inner membrane and matrix compartments. Transfer of this
Type II RNA into the matrix was strongly stimulated by the
Type I tRNATyr (Fig. 3A and B), as previously observed (18).
The effector activity of tRNATyr was sensitive to micrococcal
nuclease (Fig. 3C), but not to DNase (data not shown),
con®rming that the effector is RNA in nature and not some
adventitious contaminant of the RNA preparation. Effector-
dependent import of the Type II RNA, like the effector-
independent import of Type I RNA, was sensitive to CCCP
(Fig. 3D). Moreover, import of tRNAGln(CUG), which is not
imported in vivo, could not be induced by either Type I or
Type II effector (Fig. 3E±G), implying that the effector does
not cause a non-speci®c opening of import channels, but that
the interactions are con®ned to importable RNAs.
Identi®cation of effector domains in tRNATyr and
tRNAIle
It is evident that each tRNA has two activities: as substrate for
import, and as effector for the modulation of import of other
tRNAs. It was necessary to determine whether the two
activities are coincident in the molecule, or whether they
reside in different domains. The import signal of tRNATyr has
been localized to the D domain (16,17). In mitoplast import
assays, an oligonucleotide containing the wild-type D domain
(Fig. 1) could completely replace the intact molecule as
positive effector for import of tRNAIle (Fig. 4A). Moreover,
effector activity was sensitive to point mutations within the D
domain (Fig. 4A). The mutation G22:C in the loop-closing base
pair, which results in destabilization of the hairpin [DG of
formation reduced from ±9.2 to ±2.2 kcal/mol (17)], resulted
in complete loss of effector activity, but restoration of the base
pair in the double mutant G22:C, C13:G partially restored
activity, emphasizing the importance of secondary structure.
Mutation of A23 to U similarly led to loss of effector activity,
but this could not be restored in the double mutant A23:U,
U12:A, indicating that at this position it is the identity of the
base that is critical. The double mutation C11:A, U12:C outside
the conserved motif, which disrupts two consecutive base
pairs (DG ±0.7 kcal/mol), also abolished activity. Importantly,
the effect of each mutation on effector activity was identical
to that on importability (17), indicating that these two
phenomena are a consequence of the interaction of the Type
I domain with a single binding site on the inner membrane.
The Type II molecule tRNAIle has a strong import signal in
the V-T region (18). By employing truncated versions of this
tRNA, we sought to localize its effector domain. Whereas
tRNAIle inhibited the inner membrane transfer of tRNATyr,
tRNAIle[1±41], spanning the D domain and the anticodon
loop, was only marginally inhibitory, while tRNAIle[42±66]
Figure 4. Localization of effector domains of tRNATyr and tRNAIle. High speci®c activity substrate (S, 50 fmol) tRNA was incubated with mitoplasts prepared
from 100 mg of mitochondria either in the absence or presence of different low speci®c activity effectors (E, 5 fmol), and the imported RNA recovered.
(A) S, tRNAIle. Lanes 2 and 7, no effector; lanes 3 and 8, E, tRNATyr; lanes 4 and 9, E, tRNATyr D arm, wild type; lane 5, E, G22:C mutant; lane 6, G22:C,
C13:G; lane 10, A23:U; lane 11, A23:U, U12:A; lane 12, C11:A, U12:C. (B) S, tRNATyr. Lane 2, no effector; lane 3, E, tRNAIle; lane 4, E, tRNAIle[1±41]; lane 5,
E, tRNAIle [42±66].
Figure 3. Speci®city of effector action. The intra-mitochondrial distribution
of tRNAIle(UAU) (A±D) or tRNAGln(CUG) (E±G) was assayed by sub-
mitochondrial fractionation after import. OM, outer membrane plus inter-
membrane space; IM, inner membrane; MX, matrix. Import assays were
performed with high speci®c activity substrate (S, 50 fmol) and low speci®c
activity effector (E, 5 fmol) in the following combinations: (A and E) no
effector; (B and F) E, tRNATyr(GUA); (C) E, micrococcal nuclease-treated
tRNATyr; (D) E, tRNATyr, import in the presence of 50 mM CCCP; (G) E,
tRNAIle.
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was more effective than the intact molecule (Fig. 4B). Thus, as
in the case of tRNATyr, the import signal and effector domains
coincide.
From the above, it is clear that the interactions between
tRNATyr and tRNAIle are effectively a re¯ection of the binding
of their respective import signal-cum-effector domains to
cognate binding sites on the inner membrane. Indeed, the
import of the D arm of tRNATyr was speci®cally inhibited by
the V-T region of tRNAIle, and vice versa (Fig. 5).
The dual activity of tRNALys
Previous experiments with import aptamers indicated that, in
addition to tRNAs such as tRNATyr and tRNAIle, which
contain single import signals, there may be tRNAs with more
than one signal. One such molecule is tRNALys(UUU). Both
the Leishmania (18) and the human (Fig. 1) varieties of this
tRNA contain the conserved Type I motif YAGAGC in the D
domain, as well as the conserved Type II motif UGGGU in the
V-T region. Human tRNALys is imported into trypanosome
mitochondria in vivo (19), indicating the recognition of a
kinetoplastid-type import signal coincidentally present on this
tRNA.
We ®rst checked whether human tRNALys is imported into
Leishmania mitochondria in vitro. Incubation of 32P-labeled
tRNALys with intact mitochondria, followed by sub-
mitochondrial fractionation, showed that a signi®cant fraction
of the tRNA was located in the matrix (Fig. 6A). Transient
transfection of promastigotes resulted in oligomycin-sensitive
mitochondrial internalization of tRNALys (Fig. 6B). The mean
value of mitochondrial uptake in vivo was 45 6 13% (n = 3) of
the total intracellular pool under these conditions. Thus,
human tRNALys is imported into Leishmania mitochondria
in vitro as well as in vivo.
Next, the effector activity, if any, of tRNALys was assessed
through its effect on known Type I and Type II tRNAs.
tRNALys inhibited the inner membrane transfer, as well as
binding, of tRNATyr (Fig. 6E), implying Type II activity,
although the extent of inhibition was somewhat less, mole for
mole, than that of the known Type II molecule tRNAIle.
tRNALys also stimulated import and binding of tRNAIle
(Fig. 6F); this is a characteristic of Type I RNA (18). In the
converse experiment, the import or binding of tRNALys
substrate in vitro was not appreciably affected by either
tRNATyr (Type I) or tRNAIle (Type II) (Fig. 6C), and this was
true at substrate:effector ratios ranging from 10:1 to 1:1 (data
not shown). Similarly, neither tRNATyr nor tRNAIle had any
effect on the internalization of tRNALys in vivo (Fig. 6D). It is
evident from these observations that the effector activity of
tRNALys is not a simple summation of Type I and Type II
interactions.
DISCUSSION
In this study we show that the interactions between tRNAs at
the inner membrane previously observed in vitro are also
demonstrable in promastigotes by co-transfection assays, but
that the effects are transient (Fig. 2). Relatively large amounts
of tRNA, accounting for up to 80% or more of the total cellular
pool, were localized in the mitochondrial fraction within a few
minutes of transfection (Figs 2 and 6). This contrasts with the
few per cent of the steady-state pool in mitochondria usually
observed in vivo (2 and references therein). A possible
explanation for the discrepancy is that the transfecting RNA
enters through the ¯agellar pocket (23), with which the
mitochondrion is in close proximity, and thus does not
equilibrate with the cytoplasmic pool within the short time-
span of experimental observation. The transience of effector
action may be due to the presence of a complex cellular pool
of endogenous tRNAs, some stimulatory and others inhibitory
for import of a particular transfecting species. It was shown
previously that the ef®ciencies of inner membrane transfer of
individual import aptamers are signi®cantly more variable
in vitro than in vivo, and that the in vitro variance could be
brought closer to the in vivo value by factoring in inter-RNA
allosteric interactions (18). This is re¯ected in the present
results: tRNATyr and tRNAIle are internalized to about the
same extent in vivo (Fig. 2), whereas the corresponding
intrinsic inner membrane transfer ef®ciencies in vitro are
quite different (Fig. 4). The transient rate effect of the
Figure 5. Inter-domain interactions. Mitoplast import assays were per-
formed with high speci®c activity substrate (50 fmol) and low speci®c
activity effector (5 fmol) in the following combinations: (A) substrate
tRNATyr D arm (wild type) in the absence (lane 2) or presence of effector:
tRNAIle (lane 3), tRNAIle[1±41] (lane 4) or tRNAIle[42±66] (lane 5).
(B) Substrate tRNAIle[42±66] in the absence (lane 1) or presence of effector:
tRNATyr (lane 2), tRNATyr D arm, wild type (lane 3), G22:C mutant (lane 4)
or G22:C, C13:G mutant (lane 5).
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co-transfecting effector could be a consequence of a decline in
its concentration in the cytoplasm, either due to degradation
or, more likely, to sequestration through import into the
mitocondrial matrix, allowing the endogenous effector pool to
take over.
Secondly, our results demonstrate that the import and
effector domains of a particular tRNA are coincident (Figs 4
and 5). The identical effects of mutations on import (17) and
Type I effector activity of the D domain of tRNATyr probably
re¯ect a common interaction with a binding site (receptor) on
the inner membrane. Similarly, the Type II effector domain of
tRNAIle co-localizes with its import signal. Since the Type I
and Type II domains contain non-identical purine-rich
sequences, their cognate biding sites are likely to be related
but distinct, but they are presumed to be in close proximity to
each other, as part of the same or different protein, and to have
conformational ¯exibility. Thus, binding of a Type I domain
to its cognate site would have two effects: import, via transfer
to the import channel, and an allosteric conformation change
in the Type II binding site, resulting in the opening up of this
site for binding a Type II RNA (Fig. 7A). Type II domain
binding would likewise lead to import of the Type II RNA, as
well as to transmission of a negative allosteric effect on the
Type I binding site (Fig. 7A).
Figure 6. Import of human tRNALys(UUU) into Leishmania mitochondria.
(A) Intra-mitochondrial distribution assay. 32P-labeled tRNALys (100 fmol)
was incubated with intact mitochondria (100 mg of protein), and its sub-
mitochondrial distribution was analyzed. (B) Promastigotes were transfected
with 500 fmol of high speci®c activity tRNALys in the absence (lanes 1 and
2) or presence (lanes 3 and 4) of 50 mM oligomycin. Total and
mitochondrial pools were recovered as in Figure 2. (C) Effect of tRNATyr
and tRNAIle on import (top) or binding (bottom) of tRNALys into or on
mitoplasts in vitro. Lane 1, tRNALys substrate alone; lane 2, substrate plus
tRNATyr effector; lane 3, substrate plus tRNAIle effector. (D) Effect of
tRNATyr and tRNAIle on internalization of tRNALys into mitochondria of
transfected cells. Co-transfection of promastigotes with high speci®c
activity human tRNALys and low speci®c activity tRNAIle (top) or tRNATyr
(bottom) was performed at effector:substrate ratios of 0 (lanes 1 and 4),
1:10 (lanes 2 and 5) and 1:5 (lanes 3 and 6), respectively. The total cellular
pool (lanes 1±3) and mitochondrial pool (lanes 3±6) were recovered in each
case. (E) Effect of tRNALys on import (top) or binding (bottom) of tRNATyr
into or on mitoplasts. Import reactions contained 50 fmol of substrate and
mitoplasts from 100 mg of mitochondria; corresponding values for binding
assays were 10 fmol and 50 mg, respectively. Substrate:effector ratio was
10:1. Lane 1, tRNATyr alone; lane 2, tRNATyr plus tRNAIle effector; lane 3,
tRNATyr plus tRNALys effector; lane 4, input tRNATyr, 1.0 and 0.5 fmol,
respectively. (F) Effect of tRNALys on import (top) or binding (bottom) of
tRNAIle. Assays were performed as in (E), except that tRNAIle was used as
substrate. Lane 1, substrate alone; lane 2, substrate plus tRNATyr effector;
lane 3, substrate plus tRNALys effector; lane 4, input tRNAIle, 5 fmol.
Figure 7. Type I and Type II interactions at the inner membrane. (A) The
Type I RNA domain (L-I) binds to the cognate site R-I, leading to its trans-
fer (blue arrow) and to positive regulation (green arrow) of the Type II site
(R-II). The latter interaction results in binding of the Type II domain (L-II).
Type II RNA is subsequently transferred (blue arrow) and also negatively
regulates site R-I (red arrow). (B) The Type I and Type II domains are part
of the same molecule. Sequential or simultaneous positive and negative
effects occur on binding sites R-I and R-II.
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We also show here that human tRNALys(UUU) is imported
into Leishmania mitochondria in vitro as well as in vivo
(Fig. 6). Recognition of a human cytoplasmic tRNA by the
kinetoplastid import apparatus is of more than academic
interest, since a number of human genetic diseases are caused
by mutations in mitochondrial tRNA genes (24), and future
therapeutic strategies might involve the introduction of critical
kinetoplastid genes into mutant cells to induce tRNA import.
Based on homology, it was predicted that tRNALys contains
both Type I and Type II motifs (Fig. 1), and this was borne out
by its ability to inhibit a Type I tRNA and stimulate a Type II
tRNA (Fig. 6). This is understandable in terms of the two-site
model in Figure 7A, in which one site is occupied by the
single-domain tRNA, the other site being available for either
domain of the double-domain tRNALys. However, the import
of tRNALys substrate both in vivo and in vitro was not affected
by either single-domain effector (Fig. 6). One explanation for
this is that at high concentrations relative to the effector, the
dual-domain tRNA can interact simultaneously or sequentially
with both Type I and Type II binding sites, thus effectively
precluding effector binding (Fig. 7B). It will be necessary to
identify the corresponding tRNA binding proteins in order to
study the details of these interactions.
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